Salivary production rates fall with age in subjects having anti-centromere, anti-Ro, and/or anti-La antibodies

Scandinavian Journal of Rheumatology

Volumn 35, Issue 1, 2006, Pages 23-28

  Takada, K ^a   Suzuki, K ^a   Okada, M ^a   Nakashima, M ^a   Ohsuzu, F ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; LA ANTIBODY; RO ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVARY GLAND FUNCTION; SEROLOGY; SEX DIFFERENCE; SJOEGREN SYNDROME; STATISTICAL SIGNIFICANCE;

AGING; ANALYSIS OF VARIANCE; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; CENTROMERE; FEMALE; HUMANS; MALE; REFERENCE VALUES; REGRESSION ANALYSIS; RIBONUCLEOPROTEINS; SALIVA; SEX CHARACTERISTICS;

EID: 32644471709     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740500311788     Document Type: Article

References (27)

1. Bell M, Askari A, Bookman A, Frydrych S, Lamont J, McComb J, et al. Sjögren's syndrome: a critical review of clinical management. J Rheumatol 1999;26:2051-61.
2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
3. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Modern Rheumatol 2004;14:425-34.
4. McCarty GA, Rice JR, Bembe ML, Barada FA Jr. Anticentromere antibody. Clinical correlations and association with favorable prognosis in subjects with scleroderma variants. Arthritis Rheum 1983;26:1-7.
5. Renier G, Le Normand I, Carrere F, Chevallier A, Hurez D. Anticentromere autoantibodies and Sicca syndrome. Br J Rheumatol 1994;33:193.
6. Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM. Subjects with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993;32:297-301.
7. Caramaschi P, Biasi P, Manzo T, Carletto A, Poli F, Bambara LM. Anticentromere antibody clinical associations. A study of 44 patients. Rheumatol Int 1995;14:253-5.
8. Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol 2001;28:2238-44.
9. Izumi M, Eguchi K, Nakamura H, Takagi Y, Kawabe Y, Nakamura T. Corticosteroid irrigation of parotid gland for treatment of xerostomia in subjects with Sjögren's syndrome. Ann Rheum Dis 1998;57:464-9.
10. Nakamura H, Kawakami A, Tominaga M, Hida A, Yamasaki S, Migita K. Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 subjects. J Lab Clin Med 2000;135:139-44.
11. Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985;28:1128-32.
12. Ship JA, Baum BJ. Is reduced salivary flow normal in old people? Lancet 1990;336:1507.
13. Ship JA, Nolan NE, Puckett SA. Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different-aged adults. J Gerontol A Biol Sci Med Sci 1995;50:M285-9.
14. Ghezzi EM, Wagner-Lange LA, Schork MA, Metter EJ, Baum BJ, Streckfus CF, et al. Longitudinal influence of age, menopause, hormone replacement therapy, and other medications, and other medications on parotid flow rates in healthy women. J Gerontol A Biol Sci Med Sci 2000;55:M34-42.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. LeRoy EC, Trojanowska M, Smith EA. The pathogenesis of scleroderma (systemic sclerosis, SSc). Clin Exp Rheumatol 1991;9:173-7.
18. Pillimer SR. Sjögren's syndrome. In Klippel JH, editor. Primer on the rheumatic diseases, 12th edn. Atlanta: The Arthritis Foundation, 2001: 377-84.
19. Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Scand J Immunol 2004;59:261-6.
20. Reina S, Sterin-Borda L, Orman B, Borda E. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications. J Neuroimmunol 2004;150:107-15.
21. McCune AB, Weston WL, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Int Med 1987;106:518-23.
22. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Int Med 1994;120:544-51.
23. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001;44:647-52.
24. Ventura A, Not T, Tommasini A, Marzari R, Sblattero D. Autoantibodies as predictors of disease. Lancet 2004;364: 1403-4.
25. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
26. Earnshaw WC, Sullivan KF, Machlin PS, Cooke CA, Kaiser DA, Pollard TD, et al. Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol 1987;104:817-29.
27. Gonzalez-Buitrago JM, Gonzalez C, Hernando M, Carrasco R, Sanchez A, Navajo JA, et al. Antibodies to centromere antigens measured by an automated enzyme immunoassay. Clin Chim Acta 2003;328:135-8.